gene

TRKB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TRKB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

938Connections
3Hypotheses
2Analyses
50Outgoing
50Incoming
0Experiments
3Debates

Summary

TRKB is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 362 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolTRKB
Chromosome9q21.33
Protein TypeReceptor
Functionis a high-affinity receptor tyrosine kinase that serves as the primary signaling receptor for brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4).
Subcellular Localization</th><td>Cell membrane, endosomes, nucleus, mitochondria</td></tr>
Molecular Weight140 kDa
Amino Acids796 aa
Exons24
PathwaysAkt, Apoptosis, Cell Cycle, Long-Term Potentiation, Mapk
UniProt IDQ16620
NCBI Gene ID4915
Ensembl IDENSG00000148053
GeneCardsTRKB
Human Protein AtlasTRKB
Associated DiseasesAging, Als, Alzheimer, Alzheimer'S Disease, Cancer
InteractionsACHE, Actin, ADAM10, AEP, AGING, AKT
KG Connections917 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: TRKB — AlphaFold Q16620 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (2)

Knowledge base pages for this entity

Canonical Page

TrkB Protein

protein · 2434 words

TRKB Gene

gene · 1383 words

Pathway Diagram

flowchart TD
    BDNF["BDNF
Brain-Derived
Neurotrophic Factor"] TRKB["TRKB
Tropomyosin Receptor
Kinase B"] FGF7["FGF7
Fibroblast Growth
Factor 7"] Neurodegeneration["Neurodegeneration
General Process"] Alzheimer["Alzheimer's
Disease"] Parkinson["Parkinson's
Disease"] ALS["Amyotrophic Lateral
Sclerosis (ALS)"] MS["Multiple
Sclerosis"] Depression["Depression
Mood Disorder"] Stroke["Stroke
Cerebrovascular
Event"] Ischemia["Ischemia
Reduced Blood
Flow"] Aging["Aging
Process"] Inflammation["Inflammation
Immune Response"] Fibrosis["Fibrosis
Tissue Scarring"] NeuroprotectiveEffects["Neuroprotective
Effects"] TissueRepair["Tissue Repair
and Regeneration"] BDNF -->|"activates"| TRKB TRKB -->|"regulates"| FGF7 TRKB -->|"promotes"| NeuroprotectiveEffects TRKB -->|"enhances"| TissueRepair TRKB -->|"therapeutic_target"| Neurodegeneration TRKB -->|"therapeutic_target"| Alzheimer TRKB -->|"therapeutic_target"| Parkinson TRKB -->|"therapeutic_target"| ALS TRKB -->|"therapeutic_target"| MS TRKB -->|"therapeutic_target"| Depression TRKB -->|"inhibits"| Aging TRKB -->|"inhibits"| Fibrosis TRKB -->|"regulates"| Inflammation Ischemia -->|"leads_to"| Stroke Aging -->|"contributes_to"| Neurodegeneration style TRKB fill:#006494 style BDNF fill:#1b5e20 style NeuroprotectiveEffects fill:#1b5e20 style TissueRepair fill:#1b5e20 style FGF7 fill:#4a1a6b style Neurodegeneration fill:#ef5350 style Alzheimer fill:#ef5350 style Parkinson fill:#ef5350 style ALS fill:#ef5350 style MS fill:#ef5350 style Aging fill:#5d4400 style Depression fill:#5d4400 style Stroke fill:#5d4400 style Inflammation fill:#ef5350 style Fibrosis fill:#ef5350

Outgoing (607)

TargetRelationTypeStr
TRKBencodesprotein0.00
Alsactivatesdisease1.00
BDNFactivatesgene1.00
Synaptic Plasticityactivatespathway1.00
Inflammationactivatesdisease0.95

Incoming (331)

SourceRelationTypeStr
TRKBencodesgene0.00
BDNFactivatesprotein1.00
BDNFassociated_withgene1.00
LSDbinds_todrug0.95
psilocinbinds_todrug0.95

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Activity-Dependent Synaptic Tagging via CREB-BDNF-TrkB Signa 0.646 synaptic-biology What determines the selectivity of compl
5-HT2A/C Silencing Enables Sustained BDNF-TrkB Signaling for 0.545 - What is the minimum effective dose of tr
HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks enhances hip 0.450 neurodegeneration What are the optimal oxygen pressure, du

Mentioning Analyses (2)

Scientific analyses that reference this entity

What genetic risk factors predispose individuals to developing CTE following rep

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.552

Digital biomarkers and AI-driven early detection of neurodegeneration

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.756

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

Hypothesis debate: APOE4 Isoform Correction via Lipidation Enhancement as CTE Ri

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

The abstract explicitly states the critical need to identify genetic risk factor

closed · Rounds: 4 · Score: 0.58 · 2026-04-16

Can speech, gait, retinal imaging, sleep, and smartphone data detect neurodegene

closed · Rounds: 4 · Score: 0.95 · 2026-04-06

Related Research

Hypotheses and analyses mentioning TRKB in their description or question text

No additional research found